These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36091946)

  • 21. Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis.
    Liang X; Cheng Z; Chen X; Li J
    Front Genet; 2022; 13():955424. PubMed ID: 36046241
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabolic syndrome related gene signature predicts the prognosis of patients with pancreatic ductal carcinoma. A novel link between metabolic dysregulation and pancreatic ductal carcinoma.
    Cai W; Bao W; Chen S; Yang Y; Li Y
    Cancer Cell Int; 2021 Dec; 21(1):698. PubMed ID: 34930261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased ASF1B Expression Correlates With Poor Prognosis in Patients With Gliomas.
    Zhu H; Ouyang H; Pan X; Zhang Z; Tan J; Yu N; Li M; Zhao Y
    Front Oncol; 2022; 12():912101. PubMed ID: 35875094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
    Dong W; Du D; Huang H
    Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma.
    Wang N; Zhu L; Xu X; Yu C; Huang X
    Comput Struct Biotechnol J; 2022; 20():4390-4401. PubMed ID: 36051873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma.
    Yang Y; Ye F; Xia T; Wang Q; Zhang Y; Du J
    BMC Cancer; 2022 May; 22(1):487. PubMed ID: 35501725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PCGF1 is a prognostic biomarker and correlates with tumor immunity in gliomas.
    Xie J; Qiao L; Deng G; Liang N; Xing L; Zhang J
    Ann Transl Med; 2022 Feb; 10(4):227. PubMed ID: 35280367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCR4 is a prognostic biomarker and correlated with immune infiltrates in head and neck squamous cell carcinoma.
    Zhang Y; Chen K; Li L; Mao W; Shen D; Yao N; Zhang L
    Ann Transl Med; 2021 Sep; 9(18):1443. PubMed ID: 34733995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma.
    Zhang Z; Shang J; Dai Z; Yao Y; Shi Y; Zhong D; Liang Y; Lai C; Yang Q; Feng T; Huang X
    Front Genet; 2022; 13():848391. PubMed ID: 35601487
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes.
    Xie H; Xu J; Xie Z; Xie N; Lu J; Yu L; Li B; Cheng L
    Front Genet; 2022; 13():919638. PubMed ID: 35783277
    [No Abstract]   [Full Text] [Related]  

  • 31. Deoxythymidylate kinase (DTYMK) participates in cell cycle arrest to promote pancreatic adenocarcinoma progression regulated by miR-491-5p through TP53 and is associated with tumor immune infiltration.
    Bao W; Yang H; Zhou S; Huang F; Wei Z; Peng Z
    J Gastrointest Oncol; 2023 Jun; 14(3):1546-1559. PubMed ID: 37435228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma.
    Wu M; Li X; Liu R; Yuan H; Liu W; Liu Z
    J Cancer; 2020; 11(21):6299-6318. PubMed ID: 33033514
    [No Abstract]   [Full Text] [Related]  

  • 33. INSC Is Down-Regulated in Colon Cancer and Correlated to Immune Infiltration.
    Yu T; Li D; Zeng Z; Xu X; Zhang H; Wu J; Song W; Zhu H
    Front Genet; 2022; 13():821826. PubMed ID: 35664320
    [No Abstract]   [Full Text] [Related]  

  • 34. Sarcosine dehydrogenase as an immune infiltration-associated biomarker for the prognosis of hepatocellular carcinoma.
    Xie H; Yang K; Qin C; Zhou X; Liu J; Nong J; Luo J; Wei Y; Hua H; Han C; Liao X; Yang C; Su H; Zhu G; Ye X; Peng T
    J Cancer; 2024; 15(1):149-165. PubMed ID: 38164283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 36. DNTTIP1 is a Prognostic Biomarker Correlated With Immune Infiltrates in Hepatocellular Carcinoma: A Study Based on The Cancer Genome Atlas Data.
    Zhu C; Tong R; Jiang X; Xiao H; Guan J; Shu J
    Front Genet; 2021; 12():767834. PubMed ID: 35265097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of Ran binding protein 1 predicts poor outcomes in hepatocellular carcinoma patients: a Cancer Genome Atlas database analysis.
    Wei Z; Duan X; Li Q; Li Q; Wang Y
    J Gastrointest Oncol; 2021 Dec; 12(6):2966-2984. PubMed ID: 35070423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression.
    Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X
    Front Oncol; 2022; 12():927988. PubMed ID: 35756681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
    Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
    J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased Expression of
    Deng P; Zhou R; Zhang J; Cao L
    J Cancer; 2021; 12(11):3239-3248. PubMed ID: 33976733
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.